Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT JOURNEY MEDICAL CORPORATION

Journey Medical Corporation (NASDAQ: DERM)
Listen to this Section


$5.26
-0.0950 ( -1.96% ) 16.6K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open $5.26
Previous Close $5.35
Volume 16.6K
Market Cap $112.09M
Day Range $5.25 - $5.44
52 Week Range $2.85 - $6.89
Shares Outstanding 20.89M
Change % -1.96%
Net Change ▼ -0.0950
Insider Ownership 0.00%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2021
Country United States
Under Writer B. Riley Securities, Roth Capital, more

Insider Ownership Transactions

Total Amount Purchased: 135,313.00

Date Type Amount Purchased Purchaser
2024-08-01 Sale -9324.00 Benesch Joseph
2024-07-23 Sale -4055.00 Benesch Joseph
2024-07-23 Sale -30000.00 Pearce Michael Cooper
2024-07-10 Sale -9728.00 Smith Justin Adam
2024-07-10 Sale -9728.00 ROSENWALD LINDSAY A MD
2024-07-10 Sale -9728.00 Toledano Miranda Jayne
2024-07-10 Sale -9728.00 Herskowitz Neil
2024-05-31 Sale -50000.00 Fortress Biotech, Inc.
2024-03-27 Buy 10000.00 ROSENWALD LINDSAY A MD
2024-03-25 Buy 30000.00 Smith Justin Adam

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
sc Insider transactions 2 Nov 29, 2024
8-k 8K-related 15 Nov 12, 2024
10-q Quarterly Reports 91 Nov 12, 2024
8-k 8K-related 15 Nov 04, 2024
upload Comment letters 2 Sep 09, 2024
corresp Comment letters 2 Aug 22, 2024
upload Comment letters 2 Aug 21, 2024
10-q Quarterly Reports 87 Aug 13, 2024
8-k 8K-related 15 Aug 12, 2024
4 Insider transactions 1 Aug 01, 2024

Latest News


× Before browsing our site, please accept our cookies policy